<p>(A) D1 dendritic cells (2×10<sup>5</sup> cells) were incubated with VLPs (5 µg) alone or formulated with E<sub>8</sub>Pam<sub>2</sub>Cys (0.01 nmoles/ml) or Alhydrogel (5 µg) in a total volume of 1 ml. For comparative purposes within all experiments, cells were also either left untreated, exposed to LPS (5 µg/ml) or to similar amounts of each adjuvant alone. Cell surface MHC class II expression was determined after 16 hours using a PE-conjugated anti-IA/IE antibody. Cells expressing low levels of MHC Class II molecules were deemed to be immature whilst those expressing high levels were considered to be mature. Shown are representative histograms depicting cell surface MHC class II expression from one of three experiments conducted separa...
The model that dendritic cell (DC) "maturation" describes the change from an immature, antigen-captu...
<p>(<b>A</b>) Immature DCs were derived from mouse bone marrow and either left untreated (none) or i...
We have studied the effects of adjuvant formulations on the activation and antigen-presenting functi...
Dendritic cells (DCs) loaded with tumour antigen have become the centrepiece of clinical trials test...
Abstract: Dendritic cells (DCs) are the most po-tent antigen presenting cells. Major histocompati-bi...
<p>Panel A shows representative histograms of surface expression of MHC class II DR molecules on cDC...
Interleukin (IL)-1 beta, IL-6, tumor necrosis factor (TNF)-alpha and prostaglandins E2 is considered...
<p>(A) BM-DCs, iniDCs and 3-days cultured de-iniDCs were stained with antibodies against the dendrit...
The round THP-1 cells changed to be adherent flatten cells (white arrows). Under forward scatter and...
<p>iDCs were generated from adherent PBMCs depleted of T cells. The adherent cells were cultured in ...
Dendritic cells mature and act as adjuvants in vivo when presenting α-Galactosyl ceramide to NKT cel...
<p>(A) BMDC were incubated with 0.1 µg of <i>Ec</i>LPS, 10 µg of <i>Ba</i>LPS or 10 µg of <i>Oa</i>L...
Background. Dendritic cells (DC) have been used for immunotherapy of malignant tumors, different kin...
Mature dendritic cells (DCs) represent, by far, the most potent antigen-presenting cells. The develo...
Dendritic cells (DC) are the professional antigen presenting cells of the immune system. Therefore, ...
The model that dendritic cell (DC) "maturation" describes the change from an immature, antigen-captu...
<p>(<b>A</b>) Immature DCs were derived from mouse bone marrow and either left untreated (none) or i...
We have studied the effects of adjuvant formulations on the activation and antigen-presenting functi...
Dendritic cells (DCs) loaded with tumour antigen have become the centrepiece of clinical trials test...
Abstract: Dendritic cells (DCs) are the most po-tent antigen presenting cells. Major histocompati-bi...
<p>Panel A shows representative histograms of surface expression of MHC class II DR molecules on cDC...
Interleukin (IL)-1 beta, IL-6, tumor necrosis factor (TNF)-alpha and prostaglandins E2 is considered...
<p>(A) BM-DCs, iniDCs and 3-days cultured de-iniDCs were stained with antibodies against the dendrit...
The round THP-1 cells changed to be adherent flatten cells (white arrows). Under forward scatter and...
<p>iDCs were generated from adherent PBMCs depleted of T cells. The adherent cells were cultured in ...
Dendritic cells mature and act as adjuvants in vivo when presenting α-Galactosyl ceramide to NKT cel...
<p>(A) BMDC were incubated with 0.1 µg of <i>Ec</i>LPS, 10 µg of <i>Ba</i>LPS or 10 µg of <i>Oa</i>L...
Background. Dendritic cells (DC) have been used for immunotherapy of malignant tumors, different kin...
Mature dendritic cells (DCs) represent, by far, the most potent antigen-presenting cells. The develo...
Dendritic cells (DC) are the professional antigen presenting cells of the immune system. Therefore, ...
The model that dendritic cell (DC) "maturation" describes the change from an immature, antigen-captu...
<p>(<b>A</b>) Immature DCs were derived from mouse bone marrow and either left untreated (none) or i...
We have studied the effects of adjuvant formulations on the activation and antigen-presenting functi...